Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

NBIXNBIX
Showing 8 of 30 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in NEUROCRINE BIOSCIENCES INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 902,788 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $118.9M as of 2026-Q1. The position was increased (+6.1% shares). NBIX represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$118.9M

Current Shares

902,788

Total Value Change

+$15.3M

Total Shares Change

+150,287

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
902,788
+6.1%
$118.9M0.0%$131.14
32
2025-Q4
Increased
850,632
+2.5%
$120.6M0.0%$140.95
31
2025-Q3
Increased
829,547
+5.0%
$116.5M0.0%$140.27
32
2025-Q2
Increased
789,715
+1.8%
$99.3M0.0%$125.42
30
2025-Q1
Increased
775,773
+1.7%
$85.8M0.0%$113.16
30
2024-Q4
Increased
762,557
+2.0%
$104.1M0.0%$137.06
31
2024-Q3
Decreased
747,291
-0.7%
$86.1M0.0%$115.06
0
2024-Q2
Increased
752,501
+3.8%
$103.6M0.0%$137.67
31

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used